Literature DB >> 10447454

Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice.

L G Chia1, D R Ni, F C Cheng, Y P Ho, J S Kuo.   

Abstract

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 5,7-dihydroxytryptamine (5,7-DHT) on striatal levels of dopamine (DA), 5-hydroxytryptamine (5-HT), and their metabolites, as well as on locomotor activity were investigated in C57BL/6 mice. The results showed that MPTP significantly increased locomotor activity and decreased striatal DA levels. However, injection of the serotonergic neurotoxin 5,7-DHT in the striatum, either alone or following high doses of MPTP, significantly decreased locomotor activity, and concomitantly decreased striatal levels of 5-HT and 5-HIAA. This study suggests that the increased locomotor activity may be due to increased striatal serotonergic activity which overcompensates for the DA deficiency. The locomotor hypoactivity, induced by 5,7-DHT, might be due to the decreased striatal levels of 5-HT and 5-HIAA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447454     DOI: 10.1023/a:1020771211305

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.

Authors:  M Massotti; A Scotti de Carolis; V G Longo
Journal:  Pharmacol Biochem Behav       Date:  1974 Nov-Dec       Impact factor: 3.533

2.  Long-term effects of 5,7-dihydroxytryptamine on brain monoamines.

Authors:  J H Jacoby; L D Lytle; M F Nelson
Journal:  Life Sci       Date:  1974-03-01       Impact factor: 5.037

3.  The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals.

Authors:  U Boschert; D A Amara; L Segu; R Hen
Journal:  Neuroscience       Date:  1994-01       Impact factor: 3.590

4.  Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.

Authors:  T Toyoshi; M Ukai; T Kameyama
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

5.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

6.  Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.

Authors:  N L Rempel; C W Callaway; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1993-05       Impact factor: 7.853

7.  Simultaneous measurement of serotonin, catecholamines and their metabolites in mouse brain homogenates by high-performance liquid chromatography with a microbore column and dual electrochemical detection.

Authors:  F C Cheng; J S Kuo; Y Shih; J S Lai; D R Ni; L G Chia
Journal:  J Chromatogr       Date:  1993-06-02

8.  Regeneration of serotonergic immunoreactive fibers in the brain of 5,6-dihydroxytryptamine treated rat.

Authors:  S Ueda; M Kawata
Journal:  J Hirnforsch       Date:  1994

9.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

10.  Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole).

Authors:  C Euvrard; J R Boissier
Journal:  Eur J Pharmacol       Date:  1980-04-11       Impact factor: 4.432

View more
  4 in total

1.  Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

Authors:  Franck Chenu; Denis J P David; Isabelle Leroux-Nicollet; Erwan Le Maître; Alain M Gardier; Michel Bourin
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

2.  Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection.

Authors:  Vinchi Wang; Lie-Gan Chia; Dah-Ren Ni; Lee-Ju Cheng; Yuh-Pin Ho; Fu-Chou Cheng; Jau-Shyong Hong
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

3.  Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.

Authors:  A H Rezvani; D Eddins; S Slade; D S Hampton; N C Christopher; A Petro; K Horton; M Johnson; E D Levin
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

4.  Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.

Authors:  Cornelius J H M Klemann; Helena Xicoy; Geert Poelmans; Bas R Bloem; Gerard J M Martens; Jasper E Visser
Journal:  Mol Neurobiol       Date:  2017-10-10       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.